A phase 1 study of CC-42344 to treat Influenza virus infections.
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2018
At a glance
- Drugs CC 42344
- Indications Influenza virus infections
- Focus Adverse reactions
- 27 Mar 2018 New trial record
- 22 Mar 2018 According to a Cocrystal Pharma media release, company expects to initiate this study in Q4 2018.